Nosocomial Pneumonia Hospital Acquired, Ventilator Associated, Healthcare Associated Pneumonia.

Slides:



Advertisements
Similar presentations
Prevention of Ventilator Associated Pneumonia
Advertisements

Controversies in Critical Care David A. Schulman, MD, MPH Chief, Pulmonary and Critical Care Medicine, Emory University Hospital Training Program Director,
Reducing Ventilator Associated Pneumonia in Adults Intensive Care Units Confidential: Quality Improvement Material.
Role of MRSA Swabs for De-escalation of Antibiotics in HCAP
Appropriate Antibiotics use in CAP and HCAP at Sisters Hospital in Syed Faraz Masood, MBBS Nashat H. Rabadi, MD, FCCP.
H CAP & H AP Pamela Charity, MD Cathryn Caton, MD, MS.
TREATMENT OF PNEUMONIA IN ADVANCED DEMENTIA Sophie Allepaerts CHU- Liège Belgium.
Ventilator Care Bundle
BSI & VAP in the PICU Jana Stockwell, MD, FAAP. Why is this important? BSI is the most common PICU nosocomial infection BSI is the most common PICU nosocomial.
Healthcare Associated Pneumonia
Ventilator Associated Pneumonia (VAP)
Health Care Associated Pneumonia Respiratory Block
gain entrance to the lungs.”
Ventilator-Associated Pneumonia. Introduction Definition 48 hours after intubation mechanically ventilated No clinical evidence of pneumonia prior to.
The Importance of Clinical Oral Care
Journal Club. Background to the paper Pneumonia is THE MOST COMMON nosocomial infection in ICU patients 12 to 18 cases per 1000 ventilator days Oropharyngeal.
Ventilator Associated Pneumonia Overview
Enoch Omonge University of Nairobi
Safer Healthcare Now! Ventilator Acquired Pneumonia Presented by Amanda Thompson, Safer Healthcare Now Facilitator April 12, 2007.
MRSA and VRE. MRSA  1974 – MRSA accounted for only 2% of total staph infections  1995 – MRSA accounted for 22% of total staph infections  2004 – MRSA.
MRSA and VRE. MRSA  1974 – MRSA accounted for only ____of total staph infections  1995 – MRSA accounted for _____ of total staph infections  2004 –
Biofilms on Medical Devices
H CAP & H AP Pamela Charity, MD Cathryn Caton, MD, MS.
Cost-Conscious Care Presentation Follow-up Chest X-Ray in Patients Admitted for Community Acquired Pneumonia Huy Tran, PGY-2 12/12/2013.
Hospital Acquired Pneumonia
Oral Care for Patients at Risk for Ventilator-Associated Pneumonia Issued April 2010.
GENERAL TEMPLATE FOR A 48”X36” POSTER Name(s) of Author(s) 1 ; Name(s) of Author(s) 2 ; Name(s) of Author(s) 3 1. Name of Institution; 2. Name on Institution;
Health Care Associated Pneumonia Respiratory Block BY PROF.A.M.KAMBAL and PROF.HANAN HABIB Department of Pathology, KSU.
Clinical Uses and Ramifications of VAE Data
PRESENTER: HALIMATUL NADIA M HASHIM SUPERVISOR: DR NIK AZMAN NIK ADIB.
Chapter 22 Pulmonary Infections. Mosby items and derived items © 2009 by Mosby, Inc., an affiliate of Elsevier Inc. 2 Objectives  State the incidence.
SPM 100 Clinical Skills Lab 1 Standard Precautions Sterile Technique Daryl P. Lofaso, M.Ed, RRT.
Part I BACKGROUND VENTILATOR ASSOCIATED PNEUMONIA.
Pneumonia Dr. Abdul-Monim Batiha Assistant Professor Critical Care Nursing Philadelphia university.
ความหมาย As Pneumonia in patient who have been on mechanical ventilation for greater than 48 hrs.
Nosocomial Pneumonia Epidemiology Common hospital-acquired infection Occurs at a rate of approximately 5-10 cases per 1000 hospital admissions Incidence.
Life-Threatening Infections: Diagnosis and Antimicrobial Therapy Selection.
SPM 100 Skills Lab 1 Standard Precautions Sterile Technique Daryl P. Lofaso, M.Ed, RRT Clinical Skills Lab Coordinator.
Pneumonia Egan’s Chapter 22. Mosby items and derived items © 2009 by Mosby, Inc., an affiliate of Elsevier Inc. 2 Introduction Infection involving the.
Hospital Acquired Pneumonia(HAP): is defined as a pneumonia which occurs after 48 hours of admission to hospital. Hospital Acquired Pneumonia(HAP): is.
Mini BAL v/s Bronchoscopic BAL PROF. PRADYUT WAGHRAY MD (CHEST), DTCD, FCCP (USA),D.SC(PULM. MEDICINE) HEAD OF DEPT. OF PULMONARY MEDICINE S.V.S MEDICAL.
CUSP 4 MVP – VAP Improving Care for Mechanically Ventilated Patients Data Feedback: SubG ETT, Head of Bed Elevation and Delirium Assessment Utilization.
Strategies to Prevent Ventilator-Associated Pneumonia in Acute Care Hospitals 2014 Update Dr Neda Alijani.
Ventilator-associated pneumonia (VAP) Ventilator-associated pneumonia (VAP) is defined as nosocomial pneumonia in a patient on mechanical ventilatory support.
Community Acquired Pneumonia (CAP)
Hospital-Acquired Pneumonia
PREVENTION Kaplan University Capstone NU499 VENTILATOR – ASSOCIATED PNEUMONIA VAP PREVENTION at Sparks Regional Medical Center.
MICROBIOLOGICAL EPIDEMIOLOGY OF RESPIRATORY SPECIMENS IN ICU PATIENTS Dr Farooq Cheema, Dr Waseem Tariq, Dr Raja Ishtiaq, Dr Tabassum Qureshi, Dr Vincent.
ICU Nosocomial Pneumonia
Diamantis P. Kofteridis, Christina Alexopoulou, Antonios Valachis, Sofia Maraki, Dimitra Dimopoulou Clinical Infectious Diseases 2010; 51(11):1238–1244.
Ventilator-Associated Pneumonia (VAP) An Overview for RC Students Special thanks to: Donald Dumford Donald Dumford Beth Israel Deaconess Medical Center.
Ventilator Associated Pneumonia. Ventilator-associated pneumonia (VAP) is a form of hospital-associated pneumonia (HAP) which develops in mechanically.
Is a Strategy Based on Routine Endotracheal Cultures the Best Way to Prescribe Antibiotics in Ventilator-Associated Pneumonia? CHEST 2013; 144(1):63-71.
Depart. Of Pulmonology and Critical Care Medicine R4 백승숙.
Community Acquired Pneumonia. Definitions Community acquired pneumonia (CAP) – Infection of the lung parenchyma in a person who is not hospitalized or.
Ventilator-Associated Pneumonia
HAP and VAP Guidelines Update
Health Care Associated Pneumonia Respiratory Block
Health Care Associated Pneumonia
Subglottic Suctioning
Figure 1. Algorithm for classifying patients with hospital-acquired pneumonia according to the Consensus Statement of the American Thoracic Society. Adapted.
Health Care Associated Pneumonia Respiratory Block
A Quick Review: Preventing Ventilator-Associated Pneumonia (VAP)
Antibiotic Resistance in Nosocomial Respiratory Infections
Surveillance of Post-operative pneumonia
Health Care Associated Pneumonia
Health Care Associated Pneumonia Respiratory Block
Community Acquired Pneumonia
Presentation transcript:

Nosocomial Pneumonia Hospital Acquired, Ventilator Associated, Healthcare Associated Pneumonia

Outline and Goals Learn Definitions of types of NP Learn Pathogenesis/Epidemiology Learn Diagnosis Learn Initial Management Learn Impact of NP Learn Prevention of NP

Hospital Acquired Pneumonia “occurs 48 hours or more after admission” “was not incubating at the time of admission” Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia American Thoracic Society and the Infectious Diseases Society of America Am J Respir Crit Care Med Vol 171. pp 388–416, 2005

Ventilator Associated Pneumonia > 48 to 72 hours on closed ventilator Non-Invasive Ventilation not a factor

Healthcare-Associated Pneumonia Nursing Home/LTCH resident >48Hr hospital stay in past 90 days Within past 30 days had: Wound Care or I.V. Therapy HD or Hospital Clinic visit

Pathogenesis Colonization of Lower Respiratory Tract (LRT) Vulnerable Host Defenses

Colonization LRT Microaspiration Introduction by devices (catheters, aerosolized material) Direct Leakage around ETT cuff Biofilm

Vulnerable Host Defenses Cellular/Humoral Defenses ‣ Immunosupressed, infected, surgery, organ failure, recent antibiotics, frequent transfusions of blood/blood products Mechanical Defenses ‣ Turbinates, vocal chords, ciliated epithelium, cough, acidified stomach

VAP Incidence 90% of the HAP in the ICU is VAP Incidence increases over time but risk highest early in vent course 3%/day from day 0 to 5, 2%/day from day 5-10, 1%/day after So risk starts at minute zero of intubation

Microbiology Frequently polymicrobial Multidrug Resistance (MDR) Problem Similar spectrum in all types NP Viral/Fungus very uncommon

Aerobic Gram Negatives Pseudomonas Klebsiella Acinetobacter Very Institution Specific Stenotrophomonas Legionella

Gram Positives Most commonly staph ICU in USA MRSA>MSSA Pneumococcus much less common

Risk for MDR HCAP risks >5 days since admission Antibiotics in past 90 days Immunosupressed High MDR rate in hosp/unit

Suspect Pneumonia if: New/Progressive CXR findings Clinical Infection Findings Fever, Leukocytosis, Leukopenia Respiratory Findings Purulent Sputum, Deoxygenation

Additional Clinical Clues Mental Status Change in Elderly New Crackles, Egophony Worsening Dyspnea or Cough Increased Need for Vent Support Increased Suction Requirements

Diagnosis: Cultures Sensitivity and specificity poor with clinical criteria alone especially with vented patients CXR+ and 2/3 clinical findings present sensitivity 69% specificity 75% Fabregas et al, Thorax 1999;54:867–873

Lower Respiratory Cx Bronchoscopy or ETT Aspiration Both good NPV (>90%) ETT aspirate can’t distinguish colonizers; may lead unnecessary abx Bronch invasive; not as accessible

Blood Cultures Always obtain Limited sensitivity (25%)* May be extrapulmonary so limited specificity* For non-vented patients may be only accessible culture *Luna CM et al, Chest 1999;116:1075

Microbiological Diagnosis Culture if clinically suspect NP, BEFORE antibiotics if possible Always try LRT Cx or Sputum Always blood culture Avoid unnecessary sampling to prevent unneeded abx and MDR

Initial Management Empiric early therapy with APPROPRIATE antibiotics Do not delay therapy for microbiological sampling Delay in therapy has higher mortality

Appropriate Antibiotics? HAP with no MDR risks? Becoming less common, but can use Ceftriaxone Ampicillin/sulbactam Moxifloxacin

Appropriate Antibiotics Otherwise should start with Antipseudomonal therapy Cefepime, Imipenem, Meropenem plus MRSA Therapy Vancomycin, Linezolid

Impact of HAP/VAP 25% ICU infections HAP Most common cause for antibiotic use in ICU - likely contributor to MDR HAP extends LOS by 7-10 days Mortality ranges % Cost of one case $40,000

Prevention We give patients this. The chief complaint on entering the health care system is never: “I have ventilator associated pneumonia” Everyone who touches the patient has a responsibility to prevent it.

Hand Washing Before and after every patient contact however small Dirty hands are lethal weapons Soap/Water 30 seconds (“Happy Birthday” or “ABC” twice) Alcohol Scrub acceptable

Circuit Integrity The ventilator tubing (called “circuitry”) is changed weekly More frequent changes do not reduce VAP Avoid opening it unnecessarily - use in- line suction catheter if possible

Patient Positioning Elevate Head of Bed (HOB) to 30-45˚ Reduces clinical rate from 34% to 8%* Reduces culture rate from 23% to 5% * Every vented patient should have HOB >30˚at all times from the start unless absolute contraindication Lancet 1999 Nov 27;354:1851

Judicious Intubation Cannot get VAP if not on the Vent NIPPV good for CHF, COPD Not good for AMS, Secretions Do not delay necessary intubations

Removal of Ventilator Cannot get VAP if not on the Vent Patients need aggressive weaning Includes daily waking from sedation Includes daily wean trials if meets criteria (see weaning protocol)

IHI Bundle 1. HOB Elevation 2. Daily Sedation Vacation 3. Daily Wean Trials 4. DVT Prophylaxis 5. GI Ulcer Prophylaxis

Some institutions self-report VAP rates of 0% after adopting IHI bundle Only 3/5 recommendations directly impact VAP

HAP/VAP/HCAP significant cause of hospital/ICU Morbidity Significant cost in resources, patient safety and likely mortality Significant public health problem; possibly fueling development of MDR Summary

Once suspect diagnosis must attempt to confirm with cultures Empiric antibiotics must be started quickly Coverage for MRSA and Pseudomonas in most cases is warranted

Summary Rapid de-escalation of antibiotics Narrow if pathogen known Remove if improves and cultures negative

Summary Prevention Essential Handwashing and Infection Control HOB elevation Avoid unnecessary intubation Wake and Wean Aggressively Maintain Circuitry Integrity